title: Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
authors.affiliation: Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH. Electronic address: Craig.Vargo@osumc.edu.
authors.forename: Craig A
authors.initials: CA
authors.lastname: Vargo
authors.affiliation: Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH.
authors.forename: Marlo
authors.initials: M
authors.lastname: Blazer
authors.affiliation: Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH.
authors.forename: Joshua
authors.initials: J
authors.lastname: Reardon
authors.affiliation: Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Martha
authors.initials: M
authors.lastname: Gulati
authors.affiliation: Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Tanios
authors.initials: T
authors.lastname: Bekaii-Saab
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D066126:Cardiotoxicity / Q000188:drug therapy / Q000209:etiology; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003329:Coronary Vasospasm / Q000139:chemically induced* / Q000188:drug therapy; D004110:Diltiazem / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D014665:Vasodilator Agents; D004110:Diltiazem; D009543:Nifedipine; D002955:Leucovorin; D005472:Fluorouracil
keywords: 5-Fluorouracil; Cardiotoxicity; Colon cancer; Fluoropyrimidines; Vasospastic angina